Sensorion’s Seliforant to treat AUV fails to meet primary endpoint in phase 2b trial

Image: Seliforant fails has failed to meet primary endpoint in phase 2b hearing loss disorder trial. Photo: courtesy of Anemone123 from Pixabay.